BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2000

View Archived Issues

Ilex Oncology reports significant Q3 events

Read More

Copernicus reaches milestone in gene delivery approach to CF

Read More

Inspire reports progress in third quarter

Read More

Small-molecule Bcl-2 inhibitors sought by Structural Bioinformatics under SBIR grant

Read More

Company Profile: Angiogene

Read More

Astelin Nasal Spray approved in U.S. for treatment of nonallergic vasomotor rhinitis

Read More

MBI-594AN advances to phase II for treatment of acne

Read More

Forest to market Recordati's lercanidipine in U.S.

Read More

Investigational drug for ED discovered by Fujisawa now licensed to TAP

Read More

FDA to fast-track review of ISIS-3521 for NSCLC

Read More

IMC-C225/irinotecan shows promise for colorectal cancer in phase II trial

Read More

Gene discovery collaboration announced by Rosetta and Gemini

Read More

Neurocrine Biosciences to begin U.S. trials with altered peptide ligand for type 1 diabetes

Read More

New PARP inhibitors potentiate antitumor activity of DNA-damaging agents

Read More

Spisulosine, a marine natural product with selective activity against solid tumors

Read More

NCI-EORTC-AACR news: orally active dual topo I and II inhibitor profiled by Xenova

Read More

Second-generation tubulin-binding antitumor agent T-900607: design and characterization

Read More

Major breakthrough in HBV therapy reported at AASLD

Read More

Data presented at Heat Shock Proteins symposium support clinical application of HspE7

Read More

Significant reduction in HBV DNA obtained on adefovir dipivoxil in lamivudine-resistant HBV patients

Read More

In vivo interactions between coronary vasodilators S-nitrosocaptopril and nitroglycerin

Read More

Akzo Nobel claims new series of orally active androgens

Read More

Selective ERbeta receptor agonists synthesized by Akzo Nobel

Read More

Two series of CRF antagonists and their use in depression, anxiety, etc., presented by DuPont

Read More

Novel peptides for HCV infection emerge from R&D at Boehringer Ingelheim

Read More

Glycopeptide antibiotics discovered under joint Incara/Princeton research program

Read More

Inhibitors of cell cycle kinases and their use as anticancer agents disclosed in recent patent

Read More

Novel water-soluble trioxanes prepared at Johns Hopkins for malaria Rx

Read More

French investigators patent LTA4 hydrolase inhibitor series

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Atai Therapeutics patents new 5-HT2 receptor agonists

    BioWorld Science
    Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing